Servier to Acquire Day One Biopharmaceuticals in a $2.5 Billion Cash Deal
France‑based Servier announced a $2.5 billion all‑cash acquisition of U.S. biotech Day One Biopharmaceuticals. The tender offer prices Day One shares at $21.50, a 68.23% premium, equating to 8.34 times the company’s sales. Servier will fund the transaction with existing cash and expects the deal to close in the second quarter of 2026. The purchase expands Servier’s oncology portfolio, especially in genetically defined and pediatric cancers, and deepens its footprint in the United States.
Whither 122(18)?
In late January, VC Zurn denied a temporary restraining order seeking to block the Fifth Third‑Comerica merger, rejecting the plaintiff’s claims under both Unocal fiduciary standards and Delaware General Corporation Law §141(a). The plaintiff contended that the merger’s “no‑shop” provisions violated...
Antitrust: Trump 2.0’s “Deal Friendly” Merger Review
The DOJ and FTC under the Trump‑era “Deal Friendly” approach have shifted toward expediting non‑problematic mergers, reviving early termination practices, and favoring structural remedies such as divestitures. In 2025, agencies filed 12 enforcement actions, with nine settled via consent orders,...
Top 3 SPAC Targets – Agriculture
The column revives its Top 3 SPAC Targets list, spotlighting Costa Group, Amber Wave and Better Beef as prime agricultural merger candidates. It ties renewed SPAC activity to shifting trade policies, notably the Supreme Court’s removal of Trump‑era tariffs, and...
The SCOTUS Tariff Decision as a Subsequent Event
The Supreme Court’s ruling in Learning Resources v. Trump is being classified as a non‑recognized (Type 2) subsequent event under ASC 855 for firms that imported goods subject to IEEPA tariffs and have not yet issued financial statements as of February 20, 2026. The...
New Broker Search CDI Will Facilitate Shareholder Approval of Deals
The SEC’s Corporate Finance Division issued a new Compliance Disclosure Interpretation (CDI) that relaxes the 20‑business‑day rule for broker searches ahead of shareholder meetings. The guidance lets companies set record dates earlier, giving them more flexibility when seeking shareholder approval...
The Pros and Cons of IPOs and SPAC Mergers
The article examines whether fast‑growing firms should go public via a traditional IPO or a SPAC merger, emphasizing the role of forward‑looking statements. SPAC deals historically allow more detailed projections, which can attract both sophisticated and unsophisticated investors. The SEC’s...
Royal Cup Coffee and Tea to Acquire Farmer Bros. For $89.62 Million in Cash
Royal Cup Coffee and Tea announced a cash acquisition of Farmer Bros. Co. for $89.62 million, paying $1.29 per share—a 13.42% discount to the prior close. The transaction values Farmer Bros. at roughly 16.66 times EBITDA. The deal, advised by North...
M&A Activism: What to Expect in 2026
M&A‑focused activist campaigns surged in late 2025 and are projected to intensify throughout 2026. Activists are zeroing in on cash‑rich small‑ and mid‑cap public companies, especially those overlooked by the AI boom but with solid fundamentals. They are increasingly partnering...
GalaxyEdge Acquisition Corporation (GLED.U) Prices $100M IPO
GalaxyEdge Acquisition Corporation announced pricing of its $100 million initial public offering, with units slated to begin trading on the NYSE under the ticker GLED.U on March 4, 2026. The SPAC, led by CEO Ping Zhang and a board that includes Qi Gong,...
Kensington Capital Acquisition Corp. VI (KCAC.U) Prices $200M IPO
Kensington Capital Acquisition Corp. VI priced a $200 million initial public offering and will begin trading on the NYSE under the ticker KCAC.U on March 4, 2026. The SPAC targets a high‑growth merger in automotive, defense, energy, or artificial‑intelligence sectors. Its sponsor team...
TalkTalk to Get £115m Funding Injection From Ares Management
TalkTalk secured a £115 million cash injection from Ares Management, comprising £65 million of senior debt and a £50 million short‑term facility to replace a £47 million debt due in March. The funding follows earlier capital raises of £235 million in December 2024 and £120 million...
InsideArbitrage Event Driven Monitor – March 3, 2026
The March 3 2026 InsideArbitrage Event‑Driven Monitor reports a flurry of high‑profile M&A activity, including Global Infrastructure Partners and EQT’s $33.4 billion acquisition of AES at a 13.2% discount and a co‑founder‑led consortium’s $3.9 billion purchase of Select Medical at a 10% premium. Pending...
![[Update & Reveal] John Wood Group: Buyer Lock-In via Lending Pays Off: Double-Digit Gains Since January](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://substackcdn.com/image/fetch/$s_!B5NZ!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F32978d04-1cd9-421d-91c4-d4ab686c7abd_577x577.png)
[Update & Reveal] John Wood Group: Buyer Lock-In via Lending Pays Off: Double-Digit Gains Since January
John Wood Group’s merger with Sidara has cleared all antitrust and regulatory hurdles, confirming the buyer’s lock‑in strategy that began with a $250 million loan injection. The regulatory green light on March 3 triggered a share price rise to 28.70 pence, delivering double‑digit...
Co-Founder Robert Ortenzio-Led Consortium to Take Select Medical Private for $3.9 Billion
Select Medical Holdings agreed to be taken private for $3.9 billion by a consortium led by co‑founder Robert Ortenzio, senior executive Martin Jackson, and private‑equity firm WCAS. The deal offers $16.5 in cash per share, a 10% premium to the prior...
Consilium Introduces Insurance Policy Tailored for Private Equity Firms
Consilium, a specialty re/insurance broker, has launched a dedicated policy for private‑equity firms within its Professional & Executive Risks division. The product, crafted with in‑house legal counsel, covers professional liability, crime, directors‑and‑officers, cyber and portfolio‑company risks under a single solution....
With New DealRoom Features for Roll-Ups, Corp Dev Teams Can Eliminate Manual and Repetitive Tasks that Get in the Way...
DealRoom launched a Roll‑Up Bundle aimed at private‑equity‑backed companies that run multiple acquisitions simultaneously. The bundle adds Enhanced Permissions, Multi‑Room Updates, Template Rooms, and a Project Management Suite to automate repetitive M&A tasks. By centralizing access controls, standardizing deal rooms,...
![How to Improve Your M&A Process Using Agile [Must Read]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://cdn.prod.website-files.com/5a710020b54d350001949426/5e975c0ed4e0eadb8569babe_Artboard%201-100.avif)
How to Improve Your M&A Process Using Agile [Must Read]
Kison Patel’s new book *Agile M&A* proposes a project‑management framework that brings responsiveness, collaboration, and continuous improvement to the traditionally rigid M&A process. In a recent interview, Patel explains how techniques such as backlogs, short stand‑up meetings, and cross‑functional squads...
How DealRoom Pipeline Prevents Deals From Slipping Through the Cracks
DealRoom Pipeline introduces a unified platform for M&A deal management, consolidating emails, documents, notes, and task tracking in one view. The solution offers customizable Kanban or spreadsheet‑style pipelines, allowing teams to filter deals by priority, region, or financial metrics. Integrated...
.avif)
When to Work With Private Sellers Versus Advisors in M&A
National Express has completed roughly 30 acquisitions of family‑owned transportation firms, largely by contacting private sellers directly. The company balances the benefits of broker‑mediated deals—more organized processes—with the flexibility of unrepresented negotiations, where early valuation ranges help manage inflated seller...
.png)
Top 10 DealRoom Platform Tips to Elevate Your Dealmaking
DealRoom released a practical guide outlining ten actionable tips to streamline M&A deal management. The advice ranges from creating reusable template rooms and assigning stakeholder followers to leveraging dynamic work‑lists, audit logs, and automated dashboard reports. By optimizing document handling,...
Why You Should Focus Less on Cost Synergies During PMI
In a recent podcast, Anirvan Sen of Fifth Chrome argues that post‑merger integration should prioritize growth capabilities and revenue synergies over traditional cost‑cutting targets. He advocates a blueprint‑style integration plan that starts at the strategy stage, mapping key customer journeys...
New SPACs: RMG ML Sports Holdings (SHOTU), Mercator Acquisition Corp. (MRCOU) File for IPOs
RMG ML Sports Holdings and Mercator Acquisition Corp have each filed S‑1 registration statements to launch new special purpose acquisition companies (SPACs). RMG ML Sports will trade under the ticker SHOTU and focuses on sports‑media and technology investments, while Mercator...
Finding Value in Numbers With Ehsan Ehsani – The Special Situations Report Episode 56
Episode 56 of the Special Situations Report features Ehsan Ehsani, executive director at Crescendo Partners and Columbia Business School adjunct, promoting his new book "Finding Value in Numbers." The interview delves into quantitative investing tools, the Kelly Criterion for portfolio...
February 2026 Corporate Actions Analysis
February 2026 saw a surge in SPAC‑related corporate actions, with 45 vehicles filing deadline extensions and redemption requests climbing 30% year‑over‑year to $1.2 billion. Twelve de‑SPAC mergers closed, delivering a median post‑merger share price uplift of roughly 15%. The activity reflects...
Cleary Gottlieb Discusses Delaware Chancery’s Refusal to Dismiss Aiding, Abetting in De-SPAC Transaction
The Delaware Court of Chancery refused to dismiss a claim that Jefferies, the financial advisor to Forum III, aided and abetted fiduciary breaches in a de‑SPAC merger. The court applied the Dole factors, inferring that Jefferies knowingly participated by preparing...